If you liked this article you might like

Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day

As Blue Apron Gets Torn to Shreds, Here Are Upcoming IPOs to Potentially Salvage Your Portfolio

Move Over GMO's: IPO for Gene Editor Calyxt Launches Next Week

Cellectis Gains FDA Nod to Test New Gene-Edited Cancer Treatment

Cellectis Gets FDA Nod to Test New Gene-Edited Cancer Treatment